Latest News
World’s first study of digital follow-up of patients treated with immune-checkpoint inhibitors uses Kaiku Health.
Debiopharm International working with Kaiku Health for digital patient monitoring in prostate cancer
Debiopharm Innovation Fund’s portfolio company BC Platforms to create a Health Data Discovery Platform for the UK’s National Biobank Network
Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi
BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development
Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test
Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests